CD73 is critical for the resolution of murine colonic inflammation

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Bynoe, Margaret S ^a   Waickman, Adam T ^a   Mahamed, Deeqa A ^a   Mueller, Cynthia ^a   Mills, Jeffrey H ^a   Czopik, Agnieszka ^b  

^a Department of Obstetrics Gynecology   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; CD45 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NT5E PROTEIN, MOUSE; TIGHT JUNCTION PROTEIN; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTION; WEIGHT REDUCTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; COLON; CONVALESCENCE; ENTERITIS; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; UPREGULATION;

MURINAE; MUS;

5'-NUCLEOTIDASE; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; COLON; GPI-LINKED PROTEINS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; NF-KAPPA B; PERMEABILITY; RECOVERY OF FUNCTION; TIGHT JUNCTION PROTEINS; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84869037907     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/260983     Document Type: Article

References (48)

1. Lakatos P. L., Kiss L. S., Is the disease course predictable in inflammatory bowel diseases? World Journal of Gastroenterology 2010 16 21 2591 2599 2-s2.0-77953498517 10.3748/wjg.v16.i21.2591
2. Mahida Y. R., Microbial-gut interactions in health and disease. Epithelial cell responses. Best Practice & Research Clinical Gastroenterology 2004 18 2 241 253 10.1016/j.bpg.2003.10.001 (Pubitemid 38450644)
3. Mahida Y. R., Rolfe V. E., Host-bacterial interactions in inflammatory bowel disease. Clinical Science 2004 107 4 331 341 2-s2.0-6344287661 10.1042/CS20040136 (Pubitemid 39389300)
4. Munkholm P., Langholz E., Hollander D., Thornberg K., Orholm M., Katz K. D., Binder V., Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994 35 1 68 72 2-s2.0-0028103683 (Pubitemid 24059475)
5. Sonier B., Patrick C., Ajjikuttira P., Scott F. W., Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. International Reviews of Immunology 2009 28 6 414 445 2-s2.0-71449102303 10.3109/08830180903208329
6. Newman B., Silverberg M. S., Gu X., Zhang Q., Lazaro A., Steinhart A. H., Greenberg G. R., Griffiths A. M., McLeod R. S., Cohen Z., Fernández- Viña M., Amos C. I., Siminovitch K., CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. American Journal of Gastroenterology 2004 99 2 306 315 2-s2.0-10744221095 10.1111/j.1572-0241.2004. 04038.x (Pubitemid 38279874)
7. Brant S. R., Shugart Y. Y., Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflammatory Bowel Diseases 2004 10 3 300 311 2-s2.0-2442530958 10.1097/00054725-200405000-00019 (Pubitemid 38618262)
8. Turner J. R., Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology 2009 9 11 799 809 2-s2.0-70350509805 10.1038/nri2653
9. Bjarnason I., MacPherson A., Hollander D., Intestinal permeability: an overview. Gastroenterology 1995 108 5 1566 1581 2-s2.0-0028907445 10.1016/0016-5085(95)90708-4
10. Friedman D. J., Künzli B. M., A-Rahim Y. I., Sevigny J., Berberat P. O., Enjyoji K., Csizmadia E., Friess H., Robson S. C., CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proceedings of the National Academy of Sciences of the United States of America 2009 106 39 16788 16793 2-s2.0-70349745514 10.1073/pnas.0902869106
11. Louis N. A., Robinson A. M., MacManus C. F., Karhausen J., Scully M., Colgan S. P., Control of IFN- α A by CD73: implications for mucosal inflammation. Journal of Immunology 2008 180 6 4246 4255 2-s2.0-44849106271
12. Selmeczy Z., Csóka B., Pacher P., Vizi E. S., Haskó G., The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice. Inflammation Research 2007 56 5 204 209 2-s2.0-34250810758 10.1007/s00011-006-6150-7 (Pubitemid 46985835)
13. Cruz C. M., Rinna A., Forman H. J., Ventura A. L. M., Persechini P. M., Ojcius D. M., ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. The Journal of Biological Chemistry 2007 282 5 2871 2879 2-s2.0-34047261260 10.1074/jbc.M608083200 (Pubitemid 47084344)
14. Haskó G., Linden J., Cronstein B., Pacher P., Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nature Reviews Drug Discovery 2008 7 9 759 770 2-s2.0-51049101334 10.1038/nrd2638
15. Airas L., Niemelä J., Salmi M., Puurunen T., Smith D. J., Jalkanen S., Differential regulation and function of CD73, a glycosyl- phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. Journal of Cell Biology 1997 136 2 421 431 2-s2.0-0031047221 10.1083/jcb.136.2.421 (Pubitemid 27063091)
16. Antonioli L., Fornai M., Colucci R., Ghisu N., Tuccori M., Del Tacca M., Blandizzi C., Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflammatory Bowel Diseases 2008 14 4 566 574 2-s2.0-42449140622 10.1002/ibd.20316 (Pubitemid 351571838)
17. Gessi S., Merighi S., Varani K., Cattabriga E., Benini A., Mirandola P., Leung E., Mac Lennan S., Feo C., Baraldi S., Borea P. A., Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine subtype. Journal of Cellular Physiology 2007 211 3 826 836 2-s2.0-34247642621 10.1002/jcp.20994 (Pubitemid 46683050)
18. Hart M. L., Henn M., Köhler D., Kloor D., Mittelbronn M., Gorzolla I. C., Stahl G. L., Eltzschig H. K., Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. The FASEB Journal 2008 22 8 2784 2797 2-s2.0-48749125421 10.1096/fj.07-103911
19. Synnestvedt K., Furuta G. T., Comerford K. M., Louis N., Karhausen J., Eltzschig H. K., Hansen K. R., Thompson L. F., Colgan S. P., Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. Journal of Clinical Investigation 2002 110 7 993 1002 2-s2.0-0036771775 10.1172/JCI200215337
20. Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J. F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Journal of Experimental Medicine 2007 204 6 1257 1265 2-s2.0-34250351459 10.1084/jem.20062512 (Pubitemid 46919862)
21. Odashima M., Bamias G., Rivera-Nieves J., Linden J., Nast C. C., Moskaluk C. A., Marini M., Sugawara K., Kozaiwa K., Otaka M., Watanabe S., Cominelli F., Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 2005 129 1 26 33 2-s2.0-22344435384 10.1053/j.gastro.2005.05.032 (Pubitemid 41002039)
22. Siegmund B., Rieder F., Albrich S., Wolf K., Bidlingmaier C., Firestein G. S., Boyle D., Lehr H. A., Loher F., Hartmann G., Endres S., Eigler A., Adenosine kinase inhibitor GP515 improves experimental colitis in mice. Journal of Pharmacology and Experimental Therapeutics 2001 296 1 99 105 2-s2.0-0035193261 (Pubitemid 32015066)
23. Thompson L. F., Eltzschig H. K., Ibla J. C., Van De Wiele C. J., Resta R., Morote-Garcia J. C., Colgan S. P., Crucial role for ecto-5′- nucleotidase (CD73) in vascular leakage during hypoxia. Journal of Experimental Medicine 2004 200 11 1395 1405 2-s2.0-10644240767 10.1084/jem.20040915 (Pubitemid 39657287)
24. Whittem C. G., Williams A. D., Williams C. S., Murine Colitis modeling using Dextran Sulfate Sodium (DSS). JoVE: Journal of Visualized Experiments 2010 35, article e1652 10.3791/1652 2-s2.0-77449133183
25. Obata Y., Takahashi D., Ebisawa M., Kakiguchi K., Yonemura S., Jinnohara T., Kanaya T., Fujimura Y., Ohmae M., Hase K., Ohno H., Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis. Journal of Immunology 2012 188 5 2427 2436 2-s2.0-84857467280 10.4049/jimmunol.1101128
26. Mills J. H., Alabanza L., Weksler B. B., Couraud P. O., Romero I. A., Bynoe M. S., Human brain endothelial cells are responsive to adenosine receptor activation. Purinergic Signalling 2011 7 2 265 273 2-s2.0-79960997915 10.1007/s11302-011-9222-2
27. Powrie F., T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995 3 2 171 174 2-s2.0-0029085294
28. Powrie F., Leach M. W., Mauze S., Caddle L. B., Coffman R. L., Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. International Immunology 1993 5 11 1461 1471 2-s2.0-0027517545 (Pubitemid 23325202)
29. Mills J. H., Thompson L. F., Mueller C., Waickman A. T., Jalkanen S., Niemela J., Airas L., Bynoe M. S., CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 27 9325 9330 2-s2.0-48249097173 10.1073/pnas. 0711175105
30. Colgan S. P., Eltzschig H. K., Eckle T., Thompson L. F., Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signalling 2006 2 2 351 360 2-s2.0-33947225356 10.1007/s11302-005-5302-5
31. Ivanov A. I., Nusrat A., Parkos C. A., The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Foundation Symposium 2004 263 115 124 2-s2.0-13844312631
32. Rogler G., Andus T., Cytokines in inflammatory bowel disease. World Journal of Surgery 1998 22 4 382 389 2-s2.0-0031914778 10.1007/s002689900401 (Pubitemid 28113526)
33. Kimura K., Teranishi S., Nishida T., Interleukin-1 β -induced disruption of barrier function in cultured human corneal epithelial cells. Investigative Ophthalmology and Visual Science 2009 50 2 597 603 2-s2.0-59449092718 10.1167/iovs.08-2606
34. Beg A. A., Finco T. S., Nantermet P. V., Baldwin A. S. Jr., Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I κ B α: a mechanism for NF- κ B activation. Molecular and Cellular Biology 1993 13 6 3301 3310 2-s2.0-0027207242 (Pubitemid 23157268)
35. Kaser A., Zeissig S., Blumberg R. S., Inflammatory bowel disease. Annual Review of Immunology 2010 28 573 621 2-s2.0-77952316009 10.1146/annurev-immunol- 030409-101225
36. Morello S., Ito K., Yamamura S., Lee K. Y., Jazrawi E., DeSouza P., Barnes P., Cicala C., Adcock I. M., IL-1 β and TNF- α regulation of the adenosine receptor (A 2A) expression: differential requirement for NF- κ B binding to the proximal promoter. Journal of Immunology 2006 177 10 7173 7183 2-s2.0-33750821379 (Pubitemid 44715086)
37. Clayburgh D. R., Shen L., Turner J. R., A porous defense: the leaky epithelial barrier in intestinal disease. Laboratory Investigation 2004 84 3 282 291 2-s2.0-2142813761 10.1038/labinvest.3700050 (Pubitemid 41656483)
38. McGuckin M. A., Eri R., Simms L. A., Florin T. H. J., Radford-Smith G., Intestinal barrier dysfunction in inflammatory bowel diseases. Inflammatory Bowel Diseases 2009 15 1 100 113 2-s2.0-61949313980 10.1002/ibd.20539
39. Laukoetter M. G., Nava P., Lee W. Y., Severson E. A., Capaldo C. T., Babbin B. A., Williams I. R., Koval M., Peatman E., Campbell J. A., Dermody T. S., Nusrat A., Parkos C. A., JAM-A regulates permeability and inflammation in the intestine in vivo. Journal of Experimental Medicine 2007 204 13 3067 3076 2-s2.0-37549038994 10.1084/jem.20071416
40. Nell S., Suerbaum S., Josenhans C., The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nature Reviews Microbiology 2010 8 8 564 577 2-s2.0-77954758654 10.1038/nrmicro2403
41. Abreu M. T., Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Reviews Immunology 2010 10 2 131 143 2-s2.0-75649093343 10.1038/nri2707
42. Niess J. H., Role of gut-resident dendritic cells in inflammatory bowel disease. Expert Review of Clinical Immunology 2009 5 4 451 461 2-s2.0-77649103341 10.1586/eci.09.20
43. Fries P. N., Griebel P. J., Mucosal dendritic cell diversity in the gastrointestinal tract. Cell and Tissue Research 2011 343 1 33 41 2-s2.0-79151471820 10.1007/s00441-010-1030-4
44. Mavris M., Sansonetti P., Microbial-gut interactions in health and disease. Epithelial cell responses. Best Practice & Research Clinical Gastroenterology 2004 18 2 373 386 10.1016/j.bpg.2003.10.007 (Pubitemid 38444137)
45. Rescigno M., The intestinal epithelial barrier in the control of homeostasis and immunity. Trends in Immunology 2011 32 6 256 264 2-s2.0-79957749035 10.1016/j.it.2011.04.003
46. Wells J. M., Rossia O., Meijerink M., Van Baarlen P., Epithelial crosstalk at the microbiota-mucosal interface. Proceedings of the National Academy of Sciences of the United States of America 2011 108 1 4607 4614 2-s2.0-79952763660 10.1073/pnas.1000092107
47. Jijon H. B., Walker J., Hoentjen F., Diaz H., Ewaschuk J., Jobin C., Madsen K. L., Adenosine is a negative regulator of NF- κ B and MAPK signaling in human intestinal epithelial cells. Cellular Immunology 2005 237 2 86 95 2-s2.0-30944436237 10.1016/j.cellimm.2005.10.005 (Pubitemid 43117204)
48. Lee J., Mo J. H., Katakura K., Alkalay I., Rucker A. N., Liu Y. T., Lee H. K., Shen C., Cojocaru G., Shenouda S., Kagnoff M., Eckmann L., Ben-Neriah Y., Raz E., Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nature Cell Biology 2006 8 12 1327 1336 2-s2.0-33751551466 10.1038/ncb1500 (Pubitemid 44835107)